SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
Peter G. Eames was appointed President and Chief Executive Officer effective August 6, 2026, and nominated to the Board of Directors. Eames, who has served as Vice President of Advanced Technology since 2016, will receive a base salary of $260,000 plus performance-based compensation. This appointment follows the planned retirement of Daniel A. Baker, who has led the company since 2001.
View raw filing on EDGAR →Happen, Inc. (formerly LendingClub Corporation) completed a corporate name change and transferred its listing from NYSE to Nasdaq under the new ticker symbol 'HAPN' (formerly 'LC'). The company also changed the name of its banking subsidiary to align with the new corporate identity.
View raw filing on EDGAR →Mark A. Pytosh stepped down from his position as President and Chief Executive Officer of CVR Energy and CVR GP, and from both boards, effective June 18, 2026, pursuant to a Separation Agreement, with a separation payment of $3,000,000 and post-employment restrictions.
View raw filing on EDGAR →Dane Neumann was promoted from Executive Vice President and Chief Financial Officer to President and Chief Executive Officer of CVR Partners and its general partner, effective June 18, 2026, following Mark Pytosh's resignation.
View raw filing on EDGAR →This is a clear disclosure of shareholder voting results from HireQuest's 2026 Annual Meeting of Stockholders held on June 18, 2026. The filing reports final voting tallies for three proposals: election of six directors, ratification of Forvis Mazars as independent auditor, and a non-binding advisory vote on named executive officer compensation. This is a quintessential Item 5.07 disclosure and material to investors as it reflects stockholder approval of governance and oversight matters.
View raw filing on EDGAR →Fluent announced the launch of "Fluent In-Store," a new commerce media offering for physical retail environments built on a partnership with Bilt Technologies and deploying at Beyond, Inc. locations. This is a material operational and strategic business development—a new product line and market expansion—that does not fit a more specific category. The disclosure is made under Regulation FD (Item 7.01), indicating it is material information being disclosed to investors.
View raw filing on EDGAR →Capstone Holding Corp. amended two existing credit agreements: the Berkshire Bank Revolving Credit Agreement (extending maturity to December 31, 2026) and the Stream Finance Credit Agreement (extending maturity to September 30, 2028). The amendments modify material direct financial obligations with outstanding balances of $9.6M revolving and $2.6M principal plus $524K accrued interest, affecting the Company's capital structure and liquidity position.
View raw filing on EDGAR →At Capstone Holding Corp.'s June 18, 2026 annual meeting, shareholders approved six proposals with substantial majorities: election of Class I and Class II directors, ratification of GBQ Partners LLC as auditors, approval of a reverse stock split (1-for-5 to 1-for-50 ratio), amendment to the 2025 Stock Incentive Plan to increase share availability from 21.5% to 35%, and adjournment of the meeting.
View raw filing on EDGAR →Genprex announced a Canadian patent allowance for Reqorsa® in combination with PD-1/PD-L1 antibodies for lung cancer treatment, expanding its intellectual property portfolio across multiple jurisdictions. While patent issuances are typically routine, this disclosure emphasizes the strategic importance of IP protection for the Acclaim-3 clinical trial and the company's competitive positioning in oncology, making it a material operational/strategic milestone rather than a routine administrative matter.
View raw filing on EDGAR →This Item 5.07 filing discloses the results of Sypris Solutions' Annual Meeting of Stockholders held on June 16, 2026, including voting outcomes for the election of Class III directors (William G. Ferko and Jeffrey T. Gill) and an advisory vote on named executive officer compensation. The disclosure presents vote tallies (FOR, AGAINST, WITHHELD, ABSTAIN, and BROKER NON-VOTES) for each proposal, which is the standard format for shareholder vote results required under Item 5.07.
View raw filing on EDGAR →Hydrofarm received a Nasdaq extension letter on June 16, 2026, indicating the company failed to maintain minimum stockholders' equity of $2,500,000 under Nasdaq Listing Rule 5550(b). The filing explicitly states that if the company fails to evidence compliance by its Q3 2026 periodic report filing, "the Company may be subject to delisting." This is a direct notice of delisting risk and failure to satisfy continued listing requirements, the hallmark of the delisting_risk event type.
View raw filing on EDGAR →AXT Inc. appointed Tracy Liu to its Board of Directors as a Class II Director, effective June 17, 2026, expanding the board from four to five members. Ms. Liu, who brings over 30 years of business advisory experience including audit committee leadership at a public semiconductor company, will serve on the audit, compensation, and nominating committees.
View raw filing on EDGAR →CervoMed closed a registered direct offering of 2,500,000 shares of common stock at $4.00 per share, raising $10 million in gross proceeds pursuant to an effective Form S-3 shelf registration statement. This registered equity issuance dilutes existing shareholders and is material given the company's disclosed going-concern risks and dependence on additional financing to advance its Phase 3 trial.
View raw filing on EDGAR →The Board approved an increase to the stock repurchase program authorizing up to 26,612,580 shares (approximately 13.3% of outstanding shares). Stock repurchases are a form of capital return to shareholders and fall within the dividend_distribution category, which encompasses "share-repurchase programs" alongside dividends and distributions. The material scale (13.3% of outstanding shares) and Board approval make this material to investors assessing capital allocation and shareholder returns.
View raw filing on EDGAR →This Item 4.01 discloses the dismissal of BDO USA, P.C. as the Company's independent registered public accounting firm on June 17, 2026, and the concurrent appointment of Wipfli LLP as the new auditor. The filing explicitly states there were no disagreements or reportable events, and BDO's audit reports contained no adverse opinions or qualifications, indicating a routine auditor transition. This is a classic auditor change event material to investors' assessment of financial reporting oversight.
View raw filing on EDGAR →Rush Enterprises amended its BMO Wholesale Financing and Security Agreement to increase the total loan commitment from $171.7 million CAD to $194.7 million CAD. This represents a material increase in the company's direct financial obligations and credit facility capacity, which is a debt-related event. While this is technically an amendment to an existing credit facility rather than a new issuance, it materially expands the company's borrowing capacity and falls within the debt_issuance category as it creates or increases a direct financial obligation.
View raw filing on EDGAR →This Item 3.02 disclosure reports unregistered sales of 1,881,554 shares of common stock issued between April 1 and June 17, 2026 through warrant exercises (both cash and cashless) and a warrant exchange agreement. The largest single transaction on 6/17/2026 involved the exchange of 2,362,279 warrants for 1,616,779 shares, representing substantial dilution to existing shareholders. The securities were issued in reliance on Section 4(a)(2) and Section 3(a)(9) exemptions, confirming unregistered issuance status typical of dilutive equity raises.
View raw filing on EDGAR →Bradley E. Scher was appointed as Chairman, President, and CEO of Pacific Oak Strategic Opportunity REIT, Inc. on June 18, 2026, following the resignations of four directors and Kenneth Yee. The appointment represents a significant leadership transition and includes an engagement letter with Ocean Ridge at $12,500/month total compensation.
View raw filing on EDGAR →The filing discloses termination of a material definitive agreement referenced in Item 1.02, with cross-references to Item 5.02, but substantive details regarding the agreement's nature, termination circumstances, and financial impact are not provided in the Item classifications.
View raw filing on EDGAR →The 6-K discloses a registered direct offering of 16,571,429 Class A ordinary shares at $0.35 per share for gross proceeds of $5.8 million, entered into on June 16, 2026. This is a dilutive equity issuance of registered securities under the company's effective Form F-3 shelf registration statement, material to investors assessing ownership dilution and capital structure.
View raw filing on EDGAR →Andrew Wattula, Chief Operating Officer since 2021, resigned on June 18, 2026. The disclosure centers on his departure from a senior executive role, with his duties reassigned to existing officers while the company considers backfilling. This is a material executive departure requiring Item 5.02 disclosure.
View raw filing on EDGAR →The filing discloses entry into a material definitive credit facility (Item 1.01) consisting of a $100 million term loan and $200 million revolving credit facility with Popular Bank, closed on June 18, 2026. This represents creation of new direct financial obligations totaling $300 million in availability, with specified interest rates (SOFR + 275 bps or 5.50% floor), maturity dates, and security interests. The proceeds are designated for refinancing existing debt, acquisition growth, and general corporate purposes—a classic debt issuance disclosure.
View raw filing on EDGAR →This Item 5.07 filing discloses the results of the 2026 Annual Meeting of shareholders held on June 18, 2025, including voting outcomes on three matters: election of Class I directors (Dr. Satis Waran Nair Krishnan and Inigo Angel Laurduraj, each receiving ~69% of votes cast), ratification of SFAI Malaysia Plt. as independent auditors (78.3% approval), and advisory approval of executive compensation (68.9% approval). The filing presents tabulated voting results with vote counts and percentages for each proposal, which is the core disclosure required under Item 5.07.
View raw filing on EDGAR →The filing discloses multiple executive and board changes on June 16, 2026: resignation of Dionne Pendleton as Director, Corporate Secretary and Treasurer; appointment of Derek Wyman as Director and Treasurer; and appointment of Serge Knazev as Director and Corporate Secretary. While both departures and appointments occur, the principal disclosed actions center on the two new appointments filling vacancies and officer positions, making exec_appointment the most salient classification. The confidence is moderate (0.75) because the filing contains both a departure and multiple appointments, though the appointments are emphasized as the primary reconstitution event.
View raw filing on EDGAR →The filing discloses completion of a U.S. redomicile (corporate domicile change), commencement of drilling operations at multiple prospects (Stibium antimony and RPM gold), completion of a major geophysical survey (ZTEM), and advancement of site infrastructure and equipment procurement for antimony production. While the redomicile is a governance/structural event, the press release emphasizes operational milestones—drilling, exploration, and development activities—making this primarily an operational disclosure. The material nature is supported by the scale of activities (multiple drill rigs, US$43.4M DoD funding, 200+ square mile project) and the CEO's characterization of a "transformational period."
View raw filing on EDGAR →The filing discloses Item 5.07 results from Harrow's 2026 Annual Meeting of Stockholders held on June 18, 2026, including voting outcomes for director elections (all four nominees elected), advisory approval of named executive officer compensation, and ratification of Deloitte & Touche LLP as independent auditor. This is a standard shareholder vote results disclosure that materially informs investors of governance decisions and auditor selection.
View raw filing on EDGAR →Allison W. Brady resigned from the Board of Directors effective immediately on June 17, 2026, and also resigned from her positions on the Audit Committee and Compensation Committee. This is a clear departure of a director from the company's governance structure. The filing explicitly states her resignation was not due to disagreement, but the departure itself is a material governance event affecting board composition.
View raw filing on EDGAR →The 8-K discloses Outdoor Holding Company's financial results for the fourth fiscal quarter and full fiscal year ended March 31, 2026 via Item 2.02 (Results of Operations and Financial Condition). The press release (Exhibit 99.1) reports quarterly and annual revenue, gross profit, operating expenses, net loss, Adjusted EBITDA, and operational metrics including GMV growth and firearm unit sales increases. This is a standard earnings release disclosure material to investors assessing the company's financial performance.
View raw filing on EDGAR →The filing discloses three operational developments: achievement of 35% gross margin in May 2026 (up 660 basis points from Q1), securing Meyer Distributing as a new national B2B distribution partner, and targeting $36M+ annualized revenue opportunity. These represent material operational and commercial milestones—margin expansion, distribution scale, and revenue trajectory—that would affect a reasonable investor's assessment of the company's operational progress and cash-flow path toward profitability. While the filing is structured as a Regulation FD disclosure (Item 7.01) via press release, the substance is operational/strategic rather than fitting a specific named category like earnings_release (no full financial results), ma_activity (no acquisition/merger), or debt_issuance.
View raw filing on EDGAR →LifeMD announced a strategic co-marketing collaboration with Halozyme's subsidiary Antares Pharma to launch an exclusive telehealth program for XYOSTED (testosterone enanthate) injection, launching July 2026 in 37 states. The company will serve as the exclusive telehealth co-marketing partner, provide clinical evaluation through its medical group, and operate as the preferred dispensing pharmacy. This is a material operational and commercial partnership that expands LifeMD's service offerings and revenue opportunities, but does not fit the specific categories of M&A activity, debt issuance, or other named financial/governance events.
View raw filing on EDGAR →The filing discloses Item 5.07 results from Dyadic International's June 18, 2026 Annual Meeting of Shareholders, including voting outcomes on four proposals: election of a Class I director (Seth J. Herbst, M.D.), authorization for a reverse stock split, ratification of Crowe LLP as independent auditor, and an advisory vote on named executive officer compensation. These are standard shareholder vote results that materially inform investors about governance and capital structure decisions.
View raw filing on EDGAR →The exhibit announces a share buyback and cancellation of 6,037,851 Class A Ordinary Shares, with 32.6 million shares removed from issued capital in 8 days (27% of public float). This is a return of capital to shareholders through share repurchase and cancellation, which falls under dividend_distribution. The transaction is material as it significantly reduces share count and increases NAVPS for remaining shareholders, affecting investor valuation metrics.
View raw filing on EDGAR →The filing's primary disclosure under Item 7.01 is a press release announcing record and payment dates for cash dividends on the 9.50% Series A Perpetual Preferred Stock, with a detailed dividend schedule showing seven weekly payments of $0.1847 per share from July through August 2026. While the press release also discusses the company's ETH holdings and staking operations, the Item 7.01 filing specifically references "an update on the Company's operations and the record and payment dates for certain cash dividends," making the dividend declaration the material event being disclosed.
View raw filing on EDGAR →Cheche Group announced the commercial launch of "ABAO Agent," an AI-powered intelligent underwriting solution that represents a strategic evolution from a digital insurance transaction platform to an AI-driven insurtech company. The announcement describes autonomous capabilities deployed at scale in auto insurance renewal workflows, positioning this as a material operational and strategic milestone. While not a discrete M&A, executive change, or financial event, the launch of a proprietary AI product that the CEO characterizes as "the core engine of Cheche's intelligent transformation" and a "competitive moat" would affect a reasonable investor's assessment of the company's strategic direction and competitive positioning.
View raw filing on EDGAR →The filing discloses results of an annual meeting of stockholders held on June 18, 2026, with tabulated voting results for five proposals: election of four directors, advisory vote on executive compensation, ratification of auditor selection, authorization for a reverse stock split (1-for-10 to 1-for-50), and authorization to decrease authorized shares. This is a classic Item 5.07 shareholder vote results disclosure, and the reverse stock split authorization is material to investors as it affects share structure and capital allocation.
View raw filing on EDGAR →InterCure announced a binding term sheet for a private placement of NIS 22 million (potentially NIS 54 million) involving issuance of 7,895,143 ordinary shares at NIS 2.75 per share plus warrants to purchase an additional 7,895,143 shares. This is an unregistered equity issuance raising capital, with the securities explicitly noted as not registered under the Securities Act of 1933. The participation of the CEO and leading pharma-focused hedge funds, combined with the material capital raise and dilutive warrant component, makes this a significant dilutive issuance material to investors.
View raw filing on EDGAR →The 8-K discloses Q1 2026 financial results for INVO Fertility via Item 2.02 (Results of Operations and Financial Condition), with a press release attached as Exhibit 99.1. The filing reports revenue of $2.0 million (23% growth), net loss from continuing operations of $5.5 million, and significant balance sheet improvements including elimination of Series C-2 Preferred Stock and warrant liabilities. This is a standard quarterly earnings release material to investors assessing the company's operational and financial performance.
View raw filing on EDGAR →CIMG Inc. announced that its subsidiary Zhongyan Shangyue entered into a framework contract with Zhongshishun for construction and operation of a computing power center in Beijing, with a total contract value of up to USD 442 million over two years. This is a material operational/strategic business event involving a significant new business line (computing power services) and substantial contract value. However, the filing explicitly cautions that "there can be no assurance that the proposed project will be implemented in whole or in part" and that implementation is "subject to further arrangements, purchase orders, work orders, definitive agreements and/or satisfaction of other conditions," which introduces execution risk. The event is disclosed under Item 7.01 (Regulation FD Disclosure) rather than a dedicated M&A or contract Item, and the framework nature (rather than definitive agreement) suggests this is a preliminary arrangement rather than a binding commitment.
View raw filing on EDGAR →The filing's primary Item 5.02 disclosure centers on the resignation of James Hendrickson, President and Chief Operating Officer, effective immediately on June 15, 2026, due to disagreements with the Board regarding compensation practices and non-payment of earned wages. While the press release also announces discontinuation of AI operations and pursuit of strategic alternatives, the Item 5.02 structure and the explicit resignation statement make the executive departure the principal disclosed event, though the operational pivot is material context.
View raw filing on EDGAR →The filing discloses under Item 5.02 that the board approved annual compensation of $150,000 for Dr. Amy T. Clemens, who was recently appointed as Chief Financial Officer on June 4, 2026. While the appointment itself occurred previously, the principal disclosed action in this 8-K is the board's approval of her compensatory arrangement, making this an executive compensation disclosure rather than an appointment event.
View raw filing on EDGAR →The filing discloses a threatened shareholder derivative lawsuit in District Court Washoe County, Nevada against current and former directors and officers alleging breach of fiduciary duties and misconduct related to a $3.2 million digital currency loss. Although no complaint has yet been filed, the company received follow-up correspondence in June 2026 from the shareholder's law firm indicating intent to file and attaching a draft complaint seeking monetary and equitable relief. This constitutes material litigation disclosure under Item 8.01 (Other Events).
View raw filing on EDGAR →The filing discloses results of a special stockholder meeting held on June 18, 2026, where shareholders voted on and approved a reverse stock split proposal (1-for-2 to 1-for-20 ratio). Item 5.07 explicitly reports the voting results: 5,177,506 votes for, 1,222,793 against, 87,461 abstain. The Board subsequently approved a 1-for-20 reverse split ratio to achieve compliance with Nasdaq's $1.00 minimum bid price rule by July 31, 2026. This is a material governance event affecting share structure and listing compliance.
View raw filing on EDGAR →The filing's primary disclosure is Item 5.07 (Submission of Matters to a Vote of Security Holders), reporting results from GameSquare's June 18, 2026 Annual Meeting. While the filing also covers a merger with a wholly owned subsidiary (Item 1.01) and certificate amendments (Item 5.03), the merger is a technical recapitalization that does not involve a third party or change of control—it is a vehicle for restating the certificate of incorporation. The substantive event is stockholder approval of four proposals, including the merger agreement, director elections, auditor ratification, and say-on-pay, with detailed voting tallies provided. This is a material shareholder vote disclosure.
View raw filing on EDGAR →The filing discloses Item 5.07 results from Sidus Space's Annual Meeting of Stockholders held on June 18, 2026, including voting outcomes on four proposals: election of six directors, ratification of auditors (Fruci & Associates, PLLC), approval of equity plan share increase (800,000 to 4,800,000 shares), and rejection of an evergreen provision amendment. These are standard shareholder vote results that materially affect governance and capital structure.
View raw filing on EDGAR →The filing discloses results of a Special Meeting of Stockholders held on June 16, 2026, where shareholders voted on and approved three warrant-related proposals: authorization of warrant share issuance (including shares exceeding 19.99% of outstanding common stock), adjustment of shares issuable upon warrant exercise, and adjustment of warrant exercise prices. The vote tallies are provided for each proposal, directly matching Item 5.07 disclosure requirements for shareholder vote results.
View raw filing on EDGAR →The filing discloses expiration of 9.6 million cash warrants and cancellation of 7.1 million pre-funded warrants, eliminating 16.7 million shares of dilution overhang. While warrant expiration reduces shareholder dilution, it does not fit neatly into the taxonomy: it is neither a dilutive issuance (which involves new equity creation) nor a standard capital event. The disclosure is material to investors assessing equity structure and ownership dilution, but the specific event type—warrant expiration reducing dilution—lacks a dedicated category.
View raw filing on EDGAR →The filing discloses that Algorhythm Holdings failed to pay a $1.5 million promissory note due on May 2, 2026, and subsequently entered into two forbearance agreements (May 9, 2026 and June 16, 2026) in which the creditor waived defaults and agreed to forbear from enforcement. This is a classic covenant breach scenario—the Company triggered a payment default on a material debt obligation, and the creditor's forbearance agreements are explicit acknowledgments of the default. The escalating forbearance timeline (extended from June 16 to July 16) suggests ongoing financial stress.
View raw filing on EDGAR →The filing discloses a change in the registrant's independent accountant under Item 4.01. Sadler, Gibb & Associates, LLC was dismissed on June 17, 2026, and Wolf & Company, P.C. was appointed as the new independent registered public accounting firm on the same date. The disclosure notes a material weakness in internal control over financial reporting identified in the prior year's 10-K, which is a reportable event that was discussed with the dismissed auditor.
View raw filing on EDGAR →The filing discloses results of the Company's 2026 Annual Meeting of Stockholders held on June 16, 2026, under Item 5.07. The disclosure reports voting outcomes for two proposals: (1) election of John Smither as Class I Director with 8,696,891 votes for and 3,393,408 withheld, and (2) ratification of Weinberg & Company, P.A. as independent auditor with 28,092,768 votes for. These are standard shareholder vote results that materially inform investors of governance decisions and auditor selection.
View raw filing on EDGAR →The filing discloses the dismissal of Grant Thornton LLP as the Trust's independent registered public accounting firm effective June 16, 2026, and the engagement of Cherry Bekaert LLP as the new auditor effective June 17, 2026. This is a classic auditor change under Item 4.01. The disclosure notes a material weakness in internal control over financial reporting related to ineffective oversight of the administrator process, which is a reportable event that must be disclosed in connection with an auditor change.
View raw filing on EDGAR →